Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

Scopus Author ID: 57327734100
SciProfiles: 2301049

Countries

Italy

Activities

Collapse all

Employment (2)

Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona: Salerno, IT

2021-07-01 to present | MD (Hematology and Bone Marrow Transplant Center)
Employment
Source: Self-asserted source
Danilo De novellis

University of Salerno: Fisciano, IT

2022-11-01 to 2025-11-01 | PhD
Employment
Source: Self-asserted source
Danilo De novellis

Education and qualifications (3)

Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli: Naples, IT

2021-04-01 to 2021-06-30 | Assegno di Ricerca (Medicina Di Precisione)
Education
Source: Self-asserted source
Danilo De novellis

University of Naples Federico II: Naples, Campania, IT

2016-11-02 to 2020-10-29 | Specializzazione in Ematologia (Hematology)
Education
Source: Self-asserted source
Danilo De novellis

University of Naples Federico II: Naples, Campania, IT

2009-09-01 to 2015-07-21 | Laurea in Medicina e Chirurgia
Education
Source: Self-asserted source
Danilo De novellis

Works (23)

Efficacy of Daratumumab‐Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report

Cancer Reports
2024-11 | Journal article
DOI: 10.1002/cnr2.2149
Part of ISSN: 2573-8348
Part of ISSN: 2573-8348
Contributors: Danilo De Novellis; Pio Zeppa; Elisabetta Maffei; Valentina Giudice; Carmine Selleri; Bianca Serio
Source: Self-asserted source
Danilo De novellis

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

European Journal of Haematology
2024-10-06 | Journal article | Conceptualization
DOI: 10.1111/ejh.14314
Part of ISSN: 0902-4441
Part of ISSN: 1600-0609
Contributors: Danilo De Novellis; Daniele Derudas; Donatella Vincelli; Raffaele Fontana; Roberta Della Pepa; Salvatore Palmieri; Fabrizio Accardi; Francesco Rotondo; Emanuela Morelli; Emilia Gigliotta et al.
Source: Self-asserted source
Danilo De novellis

Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens

Cancer Medicine
2024-07 | Journal article
DOI: 10.1002/cam4.7402
Part of ISSN: 2045-7634
Part of ISSN: 2045-7634
Contributors: Danilo De Novellis; Raffaele Fontana; Bianca Serio; Emilia Vaccaro; Roberto Guariglia; Denise Morini; Michela Rizzo; Valentina Giudice; Carmine Selleri
Source: Self-asserted source
Danilo De novellis

Lenalidomide‐induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

Photodermatology, Photoimmunology & Photomedicine
2024-05 | Journal article
DOI: 10.1111/phpp.12965
Contributors: Danilo De Novellis; Annunziata Raimondo; Bianca Serio; Carlo Baldi; Valentina Giudice; Serena Lembo; Carmine Selleri
Source: check_circle
Crossref

Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience

Annals of Hematology
2024-05-28 | Journal article
DOI: 10.1007/s00277-024-05811-y
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Contributors: Giuseppe Mele; Daniele Derudas; Concetta Conticello; Gregorio Barilà; Massimo Gentile; Stefano Rocco; Salvatore Palmieri; Giulia Palazzo; Candida Germano; Giovanni Reddiconto et al.
Source: Self-asserted source
Danilo De novellis

Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients

Cancer Reports
2024-04 | Journal article
DOI: 10.1002/cnr2.2044
Part of ISSN: 2573-8348
Part of ISSN: 2573-8348
Contributors: Bianca Serio; Francesco Grimaldi; Lucia Ammirati; Mario Annunziata; Giovanna De Santis; Alessandra Perrotta; Danilo De Novellis; Valentina Giudice; Denise Morini; Gabriella Storti et al.
Source: Self-asserted source
Danilo De novellis

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience

Hematology Reports
2024-04-17 | Journal article
DOI: 10.3390/hematolrep16020023
Contributors: Bianca Serio; Gabriella Storti; Matteo D’Addona; Lidia Santoro; Camilla Frieri; Danilo De Novellis; Luana Marano; Giovanna De Santis; Roberto Guariglia; Ilenia Manfra et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies

Clinical and Experimental Medicine
2024-04-05 | Journal article
DOI: 10.1007/s10238-024-01313-3
Part of ISSN: 1591-9528
Contributors: Valentina Giudice; Monica Ianniello; Danilo De Novellis; Luca Pezzullo; Nadia Petrillo; Bianca Serio; Matteo D’Addona; Anna Maria Della Corte; Michela Rizzo; Bianca Cuffa et al.
Source: Self-asserted source
Danilo De novellis

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience

Targeted Oncology
2023-11 | Journal article
DOI: 10.1007/s11523-023-01001-4
Part of ISSN: 1776-2596
Part of ISSN: 1776-260X
Contributors: Danilo De Novellis; Raffaele Fontana; Salvatore Palmieri; Roberta Della Pepa; Maria Di Perna; Giusy Cetani; Daniela Esposito; Angela Amendola; Giuseppe Delle Cave; Bianca Serio et al.
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 2)‎

Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition

European Journal of Haematology
2023-11 | Journal article
DOI: 10.1111/ejh.14069
Contributors: Valentina Giudice; Bianca Serio; Santa Errichiello; Idalucia Ferrara; Alessandra Galdiero; Angela Bertolini; Roberta Visconti; Danilo De Novellis; Roberto Guariglia; Serena Luponio et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients

Clinical and Experimental Medicine
2023-10-28 | Journal article
DOI: 10.1007/s10238-023-01223-w
Part of ISSN: 1591-9528
Contributors: Danilo De Novellis; Veronica Folliero; Valentina Giudice; Luca Pezzullo; Giuseppina Sanna; Raffaele Fontana; Roberto Guariglia; Carla Zannella; Laura Mettivier; Idalucia Ferrara et al.
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 2)‎

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review

International Journal of Molecular Sciences
2023-06 | Journal article | Author
DOI: 10.3390/ijms241310519
Contributors: Paola Manzo; Valentina Giudice; Filomena Napolitano; Danilo De novellis; Bianca Serio; Paolo Moscato; Nunzia Montuori; Carmine Selleri
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A

Journal of Clinical Medicine
2022-12 | Journal article | Author
DOI: 10.3390/jcm12010193
Contributors: Danilo De novellis; Valentina Giudice; Vincenzo Ciccone; Paola Erra; Alba De Vita; Francesca Picone; Bianca Serio; Carmine Selleri
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance

International Journal of Molecular Sciences
2022-12 | Journal article | Author
DOI: 10.3390/ijms24010645
Contributors: Danilo De novellis; Raffaele Fontana; Valentina Giudice; Bianca Serio; Carmine Selleri
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma

Journal of Clinical Laboratory Analysis
2022-11-17 | Journal article
DOI: 10.1002/jcla.24782
Part of ISSN: 0887-8013
Part of ISSN: 1098-2825
Contributors: Danilo De novellis; Valentina Giudice; Danilo De Novellis; Roberto Guariglia; Rosalba Fumo; Giuseppe Ciancia; Bianca Serio; Carmine Selleri
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 2)‎

Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience

Frontiers in Oncology
2022-11-15 | Journal article
DOI: 10.3389/fonc.2022.1026251
Part of ISSN: 2234-943X
Contributors: Danilo De novellis; Rossella Iula; Danilo De Novellis; Fabio Trastulli; Roberta Della Pepa; Raffaele Fontana; Angela Carobene; Maria Di Perna; Alessandro D’Ambrosio; Martina Romano et al.
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 2)‎

Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study.

Biomedicines
2022-07-10 | Journal article
DOI: 10.3390/biomedicines10071657
PMID: 35884962
PMC: PMC9313319
Contributors: Danilo De novellis; De Novellis D; Fontana R; Carobene A; Serio B; Ferrara I; Martorelli MC; Mettivier L; Guariglia R; Luponio S et al.
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 4)‎

High-Risk Acute Myeloid Leukemia: A Pediatric Prospective

Biomedicines
2022-06 | Journal article | Author
DOI: 10.3390/biomedicines10061405
Contributors: Fabiana Cacace; Rossella Iula; Danilo De novellis; Valeria Caprioli; Maria Rosaria D’Amico; Giuseppina De Simone; Rosanna Cuccurullo; William G. Wierda; Kris Michael Mahadeo; Giuseppe Menna et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

The TKI Era in Chronic Leukemias.

Pharmaceutics
2021-12-20 | Journal article | Author
DOI: 10.3390/pharmaceutics13122201
PMID: 34959482
PMC: PMC8709313
Contributors: Danilo De novellis; Cacace F; Caprioli V; Wierda WG; Mahadeo KM; Tambaro FP
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 5)‎

Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia

Blood
2021-11-05 | Journal article
DOI: 10.1182/blood-2021-150484
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Contributors: Valentina Giudice; Idalucia Ferrara; Marisa Gorrese; Francesca D'Alto; Roberto Guariglia; Serena Luponio; Luca Pezzullo; Laura Mettivier; Angela Bertolini; Matteo D'Addona et al.
Source: Self-asserted source
Danilo De novellis

The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View.

Journal of experimental pharmacology
2021-10-29 | Journal article
DOI: 10.2147/jep.s265284
PMID: 34744463
PMC: PMC8565990
Contributors: Danilo De novellis; Tambaro FP; De Novellis D; Wierda WG
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 3)‎

Pneumatosis cystoides intestinalis, a rare case in a pediatric patient following allogeneic hematopoietic stem cell transplantation: CT findings and literature review.

Radiology case reports
2021-08-16 | Journal article
DOI: 10.1016/j.radcr.2021.07.053
PMID: 34457100
PMC: PMC8377547
Contributors: Danilo De novellis; Baldari D; Pizzicato P; Tambaro FP; De Novellis D; Brillantino C; Lombardo P; Castelli L; Minelli R; Zeccolini M et al.
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 3)‎

Amyloidoma of the Tongue: Case Report, Surgical Management, and Review of the Literature.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
2020-04-27 | Journal article
DOI: 10.1016/j.joms.2020.04.022
PMID: 32442425
Contributors: Danilo De novellis; Adamo D; Roberta Gasparro; Marenzi G; Massimo Mascolo; Cervasio M; Cerciello G; De Novellis D; Mignogna MD
Source: Self-asserted source
Danilo De novellis
grade
Preferred source (of 3)‎

Peer review (21 reviews for 6 publications/grants)

Review activity for Cancers. (5)
Review activity for Current oncology. (7)
Review activity for Hematology reports. (4)
Review activity for International journal of molecular sciences. (2)
Review activity for Journal of personalized medicine. (1)
Review activity for The American journal of case reports. (2)
How many people are using ORCID?